Profile image
By ETF Daily News (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Ariad Pharmaceuticals Will Be Acquired For $5.2 Billion In Cash, 75% Premium

Monday, January 9, 2017 7:17
% of readers think this story is Fact. Add your two cents.

From Cancer treatment specialist Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has agreed to be acquired by Japanese biotech giant Takeda Pharmaceuticals for $24 per share in cash, in a blockbuster health care deal.

The $5.2 billion asking price represents a massive 74.6% premium over ARIA’s Friday closing price of $13.74. The stock last traded around the $24 level back in 2012, but had spent most of the past three years hovering in the single digits.

The deal has been unanimously approved by the boards of both companies, and is expected to close in February 2017, subject to the usual shareholder and regulatory approvals. ARIA commented via press release:

“We are very pleased to combine with Takeda, which will allow us to not only accelerate our mission to discover, develop and deliver precision therapies to patients with rare cancers, but also deliver meaningful value to our shareholders through a substantial cash premium. This exciting transaction is a testament to the hard work and dedication of ARIAD’s talented team of employees. We have tremendous respect for Takeda, and I believe our shared commitment to innovation and research-driven cultures will provide for a smooth transition.”

Ariad Pharmaceuticals, Inc. shares rose $10.22 (+74.38%) in premarket trading Monday. Prior to today’s news, ARIA had gained 10.45% year-to-date, versus a 1.65% rise in the benchmark S&P 500 index during the same period.

ARIA currently has an POWR Rating of A (Strong Buy), and is ranked #5 of 250 stocks in the Biotech category.

This article is brought to you courtesy of

You are viewing an abbreviated republication of ETF Daily News content. You can find full ETF Daily News articles on (


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.